Emcure Pharmaceuticals to hold 45th AGM on Sep 21, 2026; Annual Report 2025-26 available
Emcure Pharmaceuticals will hold its 45th AGM on September 21, 2026, via video conference. The Annual Report for FY 2025-26 is available online. Members must submit TDS exemption documents by September 14, 2026, for final dividend eligibility.
This is a standard procedural announcement related to corporate governance and compliance, with no immediate material impact on the company's operations or financial performance.
The announcement is a routine update regarding the AGM and dispatch of the annual report and compliance-related information for shareholders. It does not contain significant new financial information or strategic developments that would sway sentiment.
Emcure Pharmaceuticals Limited has announced the dispatch of letters to members who have not registered their email addresses, providing a web-link and QR code for the Annual Report 2025-26 and the Notice of its 45th Annual General Meeting (AGM).
The 45th AGM is scheduled to be held on Monday, September 21, 2026, at 11:00 a.m. IST, through Video Conferencing (VC) facility or Other Audio Visual Means (OAVM). The company has provided direct web-links for both the Notice of the 45th AGM and the Annual Report for the Financial Year 2025-26.
Members are also reminded to submit TDS exemption documents for FY 2026-27 by September 14, 2026, to claim exemption from TDS on the Final Dividend for FY 2025-26, subject to shareholder approval at the AGM. Additionally, the company is reminding security holders to update their KYC details as per SEBI Master Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/91 dated June 23, 2025, and to dematerialize physical securities. Payments like dividend, interest, or redemption for folios without updated PAN, Nomination, Contact details, Bank Account details, and Specimen Signature will only be made through electronic mode from April 01, 2024.
A plain-language summary of a public exchange filing by Emcure Pharmaceuticals Limited. Read the original for the full detail.